Agenus Inc. Shareholders Invited to Join Securities Class Action
The Gross Law Firm is reaching out to shareholders of Agenus Inc. (NASDAQ: AGEN) to inform them of an opportunity to join a securities class action. Shareholders who bought shares during a specified timeframe are encouraged to contact the firm for potential participation as lead plaintiffs.
Class Period and Allegations
The class period for this action spans from January 23, 2023, to July 17, 2024. The allegations claim that the defendants made materially false statements regarding their combination therapy involving immuno-oncology products, botensilimab and balstilimab. It is alleged that the effectiveness of these therapies was overstated, resulting in misleading public statements concerning their clinical results and commercial potential.
Deadlines to Register
It is crucial for shareholders to act quickly as the deadline for registration is approaching. Interested parties should ensure their registration by November 5, 2024, to be considered for participation in the class action. This step allows shareholders to stay informed throughout the process.
Process for Shareholders
Once registered, shareholders will be enrolled in a monitoring system to receive updates about the case's progress. The Gross Law Firm assures that there are no costs or commitments required from participants to register. This represents a significant opportunity for those affected by the alleged misrepresentations to seek recovery.
Why Choose Gross Law Firm?
Known for its dedication to investor rights, The Gross Law Firm focuses on representing individuals who have suffered due to fraudulent practices. The firm emphasizes ethical business conduct and aims to hold companies accountable for their statements, ensuring transparency and accountability in the market.
Contact Information
For more inquiries, shareholders can reach out to The Gross Law Firm at their New York office located at 15 West 38th Street, 12th floor. They can also get in touch by phone at (646) 453-8903 for further assistance.
Frequently Asked Questions
What is the purpose of the securities class action?
The class action aims to seek compensation for shareholders who suffered losses due to allegedly misleading statements by Agenus Inc.
Who can join the class action?
Any shareholder who purchased Agenus Inc. shares within the defined class period is eligible to join the class action.
When is the registration deadline?
The deadline for registering in the class action is November 5, 2024.
Is there a cost to participate in the class action?
No, there is no cost or obligation for shareholders to register for participation.
How will I be updated on the case's progress?
Registered shareholders will receive updates through a portfolio monitoring system, keeping them informed of any developments in the case.
